| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
|
Liver Transpl
|
2006
|
1.86
|
|
2
|
Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
|
Gastroenterology
|
2010
|
1.85
|
|
3
|
Renal histopathological lesions after orthotopic liver transplantation (OLT).
|
Am J Transplant
|
2005
|
1.79
|
|
4
|
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
|
J Hepatol
|
2003
|
1.67
|
|
5
|
Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.
|
Liver Transpl
|
2007
|
1.64
|
|
6
|
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.
|
World J Gastroenterol
|
2006
|
1.58
|
|
7
|
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
|
Liver Transpl
|
2006
|
1.56
|
|
8
|
Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation.
|
World J Surg
|
2014
|
1.42
|
|
9
|
Split liver transplantation using extended right grafts: the natural history of segment 4 and its impact on early postoperative outcomes.
|
Liver Transpl
|
2012
|
1.40
|
|
10
|
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
|
Gastroenterology
|
2005
|
1.33
|
|
11
|
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
|
Liver Transpl
|
2005
|
1.28
|
|
12
|
Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis.
|
Hepatology
|
2004
|
1.21
|
|
13
|
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter study.
|
Gastrointest Endosc
|
2010
|
1.04
|
|
14
|
Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway.
|
Lab Invest
|
2008
|
1.00
|
|
15
|
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
|
Liver Transpl
|
2006
|
0.96
|
|
16
|
Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.
|
Transplantation
|
2003
|
0.93
|
|
17
|
Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study.
|
Liver Transpl
|
2004
|
0.93
|
|
18
|
Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis.
|
Liver Transpl
|
2011
|
0.93
|
|
19
|
Immunosuppressive therapy in liver transplantation.
|
J Hepatol
|
2003
|
0.93
|
|
20
|
A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication.
|
J Med Virol
|
2007
|
0.91
|
|
21
|
MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.
|
Cancer Lett
|
2002
|
0.88
|
|
22
|
Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
|
Liver Transpl
|
2008
|
0.88
|
|
23
|
Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.
|
J Infect Dis
|
2002
|
0.85
|
|
24
|
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.
|
FASEB J
|
2007
|
0.85
|
|
25
|
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
|
Liver Transpl
|
2009
|
0.84
|
|
26
|
Interleukin-15 production during liver allograft rejection in humans.
|
Transplantation
|
2003
|
0.81
|
|
27
|
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
|
Liver Int
|
2011
|
0.81
|
|
28
|
Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes.
|
Transpl Int
|
2002
|
0.81
|
|
29
|
Analysis of gene transcription in sera during chronic hepatitis C infection.
|
J Med Virol
|
2009
|
0.80
|
|
30
|
CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation.
|
Clin Transplant
|
2008
|
0.80
|
|
31
|
MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation.
|
Transplantation
|
2002
|
0.80
|
|
32
|
Review article: use of induction therapy in liver transplantation.
|
Transplant Rev (Orlando)
|
2012
|
0.80
|
|
33
|
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.
|
Transplantation
|
2004
|
0.80
|
|
34
|
Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt.
|
J Thorac Imaging
|
2002
|
0.80
|
|
35
|
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
|
Transplantation
|
2007
|
0.80
|
|
36
|
Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease?
|
J Hepatol
|
2009
|
0.79
|
|
37
|
Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteria.
|
Hepatogastroenterology
|
2013
|
0.79
|
|
38
|
Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
|
Liver Transpl
|
2006
|
0.79
|
|
39
|
Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis.
|
J Hepatol
|
2002
|
0.78
|
|
40
|
Biliary administration of naked DNA encoding Fas-Fc protein prevents acute liver failure in mice.
|
Hum Gene Ther
|
2002
|
0.77
|
|
41
|
Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation period.
|
J Clin Pharmacol
|
2010
|
0.77
|
|
42
|
In vitro influence of fatty acids and bilirubin on binding of mycophenolic acid to human serum albumin.
|
J Pharm Biomed Anal
|
2010
|
0.77
|
|
43
|
Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients.
|
Clin Transplant
|
2004
|
0.77
|
|
44
|
Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
|
Liver Transpl
|
2008
|
0.76
|
|
45
|
[Recurrent hepatitis C after liver transplantation: Erythropoietin allows maintenance of antiviral treatment].
|
Presse Med
|
2006
|
0.76
|
|
46
|
CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long-term survivors after liver transplantation.
|
Liver Transpl
|
2011
|
0.76
|
|
47
|
Regression of Hypervascular Nodules in a Patient with Wilson's Disease Awaiting Liver Transplantation.
|
J Transplant
|
2009
|
0.75
|
|
48
|
What Kind of Information About Marginal Donors Is Available Through Sources Other Than Health Care Professionals for Patients on the Waiting List for Organ Transplantation?
|
Interact J Med Res
|
2015
|
0.75
|
|
49
|
Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
|
Ann Surg
|
2017
|
0.75
|
|
50
|
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
|
Transplantation
|
2016
|
0.75
|
|
51
|
[Liver transplantation: 20 years of progress].
|
Presse Med
|
2009
|
0.75
|
|
52
|
Scurvy in liver transplant patients.
|
J Am Acad Dermatol
|
2006
|
0.75
|
|
53
|
Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases.
|
Transplantation
|
2006
|
0.75
|
|
54
|
Autoimmune pancytopenia as an early complication of liver transplantation: report of one case.
|
Leuk Lymphoma
|
2004
|
0.75
|
|
55
|
[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
|
Gastroenterol Clin Biol
|
2002
|
0.75
|
|
56
|
Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
|
Transplantation
|
2017
|
0.75
|
|
57
|
Thiabendazole-induced acute liver failure requiring transplantation and subsequent diagnosis of polyarteritis nodosa.
|
Clin Exp Rheumatol
|
2012
|
0.75
|
|
58
|
[Rules for allocation of livers for transplantation].
|
Presse Med
|
2008
|
0.75
|